Lataa...
High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy
BACKGROUND: Chemokine receptor CXC chemokine receptor type 4 (CXCR4) and its ligand CXC motif chemokine 12 (CXCL12; stromal cell-derived factor-1) are implicated in tumor growth, metastasis, and tumor cell-microenvironment interaction. A number of studies have reported that increased CXCR4 expressio...
Tallennettuna:
| Julkaisussa: | J Pathol Transl Med |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6250928/ https://ncbi.nlm.nih.gov/pubmed/30269472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2018.09.19 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|